Contract 75N93019F00132
The Emmes Company, Llc · Department Of Health And Human Services · November 12, 2018
The Emmes Company, Llc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on November 12, 2018 for $58.91 million of work in research and development in biotechnology. Performance is in Rockville, MD. This is a task or delivery order issued under parent IDIQ HHSN272201700051I. The contract has been modified 206 times since the base award It uses cost-plus contract pricing. The most recent modification was on January 21, 2026.
Contract details
- PIID
- 75N93019F00132
- Parent IDIQ
- HHSN272201700051I
- Award type
- Delivery Order
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- R&D- Other Research And Development (Applied Research/Exploratory Development)
- Place of performance
- Rockville, MD
- First action
- November 12, 2018
- Latest action
- January 21, 2026
Description
CLINICAL MONITORING INITIATIVE (CMI) FOR VRC 316, 317, 320, 603
Modification timeline
-
January 21, 2026Mod P00003$0
-
September 23, 2025Mod P00004THE SCOPE OF THIS TASK ORDER IS TO PROVIDE ADMINISTRATIVE, PROJECT MANAGEMENT AND OVERALL SUPPORT OF TASKS AND FUNCTIONS ASSOCIATED WITH THE OPERATION OF THE ST$-4.1K
-
September 23, 2025Mod P00005THE SCOPE OF THIS TASK ORDER IS TO PROVIDE ADMINISTRATIVE, PROJECT MANAGEMENT AND OVERALL SUPPORT OF TASKS AND FUNCTIONS ASSOCIATED WITH THE OPERATION OF THE ST$-4.1K
-
September 22, 2025Mod P00010NIAID PRECLINICAL DEVELOPMENT SUPPORT$-939.1K
-
September 4, 2025Mod P00015PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SUPPORT SERVICES TO NIAID.$-270.4K
-
July 7, 2025Mod P00006THE CONTRACTOR SHALL SUPPORT THE ADMINISTRATIVE AND TECHNICAL ACTIVITIES CONDUCTED ON A RECURRING BASIS TO PROVIDE QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) SUP$-42.4K
-
June 26, 2025Mod P00009EOI::IMPLEMENTING THE PRESIDENT'S "DEPARTMENT OF GOVERNMENT EFFICIENCY". COST EFFICIENCY INITIATIVE (FEBRUARY 26,2025)::EOI NOTICE OF TERMINATION FOR CONVENIENC$0
-
May 7, 2025Mod P00005THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE REMAINING FUNDS FROM LINES 3, 4, AND 5 OF THE TASK ORDER.$-64.2K
-
April 21, 2025Mod P00010TO DE-OBLIGATE EXPIRING FY20 FUNDS IN PRISM LINES 11 AND 16, EFFECTIVE 04/21/2025, PURSUANT TO FAR 42.302(B)(4)- RELEASE OF EXCESS CONTRACT FUNDS$-4.8K
-
April 21, 2025Mod P00003EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI TO FULLY TERMINATE THIS CONTRACT FOR CONVE$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93019F00132?
Contract 75N93019F00132 is a federal contract awarded to The Emmes Company, Llc by Department Of Health And Human Services on November 12, 2018 for $58.91 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 206 times since the base award.
Who won contract 75N93019F00132?
The Emmes Company, Llc won contract 75N93019F00132 from Department Of Health And Human Services.
How much is contract 75N93019F00132 worth?
Contract 75N93019F00132 has obligated $58.91 million to date.